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BACKGROUND
The colonization of indwelling medical devices by biofilm-forming bacteria is one of the major
causes of healthcare-associated infections (Percival et al., 2015). Staphylococcus epidermidis, a
biofilm-forming commensal bacterium that inhabits human skin and mucosae, is considered
one of most important causes of medical devices-related infections, being particularly associated
with the use of intravascular catheters (Mack et al., 2013). Although S. epidermidis biofilms
are classically associated with the development of chronic infections (Costerton et al., 1999),
the release of cells from the biofilm has been associated with onset of acute infections such as
embolic events of endocarditis (Pitz et al., 2011), bacteremia, or even septicemia (Cole et al.,
2016). Bloodstream infections caused by S. epidermidis are typically indolent and difficult to
eradicate significantly increasing patient’s morbidity (Kleinschmidt et al., 2015) and mortality
among immunocompromised (Khashu et al., 2006) and immunosuppressed patients (Bender and
Hughes, 1980). In addition, the costs associated with the diagnosis and treatment of these secondary
infections is estimated to be approximately $20,000 per occurrence (Kilgore and Brossette, 2008).
Henceforth, it is imperative to redefine strategies for the management of the pathologic events
associated with biofilm disassembly. Since bloodstream infections are one of the most frequent
complications caused by S. epidermidis biofilm disassembly (Cole et al., 2016), a comprehensive
analysis of the interplay between S. epidermidis biofilm-released cells (BRC) and hosts’ blood
components would be invaluable. Herein, as the first step toward the understanding of this
interaction, we have characterized, using RNA sequencing (RNAseq) technology, the transcriptome
of S. epidermidis BRC upon interaction with whole human blood, polymorphonuclear, or
mononuclear leukocytes and plasma.
MATERIALS AND METHODS
Ethics Statement
Human blood was collected from healthy adult volunteers, under a human subject’s protocol
approved by the Institutional Review Board of the University of Minho (SECVS 002/2014).
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Furthermore, this procedure was performed in agreement with
Helsinki declaration and Oviedo convention. All donors gave
written consent before blood collection.
Bacteria and Growth Conditions
S. epidermidis strain 9142, isolated from a blood culture (Mack
et al., 1992), was used for this study. BRC were obtained
using a fed-batch system in the presence of Tryptic Soy Broth
(TSB) supplemented with 0.65% glucose and under agitation
conditions, as detailed elsewhere (França et al., 2016). BRC cells
were collected from 12 different originating biofilms and pooled
together to decrease the variability inherent to biofilm growth
(Sousa et al., 2014). After 10 s sonication at 33% amplitude (Cole-
Parmer 750-Watt Ultrasonic Homogenizer 230 VAC, IL, USA),
the concentration of BRC was adjusted to 1 × 109 total cells/mL,
by flow cytometry (EC800, Sony Biotechnology Inc., CA, USA),
using SYBR Green (Invitrogen, CA, USA) and propidium iodide
(Sigma, MO, USA) staining as previously optimized (Cerca et al.,
2011).
Blood Collection and Fractioning
Peripheral blood was collected into BDVacutainer R© tubes coated
with lithium heparin (BD R©, NJ, USA). Plasma was separated
from the cellular fraction by centrifuging whole blood at 1440 g
for 20 min at 4◦C. Mononuclear (MN) leukocytes were purified
from whole blood using Histopaque 1077 gradient (Sigma) as
indicated by the manufacturer. Thereafter, the mononuclear
cells-depleted pellet resultant from the Histopaque 1077 gradient
was incubated with 1.5% (v/v) dextran solution during 35 min,
at room temperature, in order to separate polymorphonuclear
(PMN) cells from erythrocytes. PMN cells (present in the
supernatant) were then transferred in to a new tube and
harvested by centrifugation at 450 g for 15 min at 4◦C. Both
PMN and MN cells were incubated with water for 30 s to lyse
the remaining erythrocytes and, after readjusting the isotonic
conditions by adding 10 × PBS, leukocytes were collected by
centrifugation at 200 g for 15 min at 4◦C. Finally, leukocytes
were suspended in 0.5 mL of donor’s plasma and samples purity
and viability determined by flow cytometry (EC800, Sony) using,
respectively, CD15 (PMN) and CD3 (MN) (eBioscience, CA,
USA) and propidium iodide staining (5 µg/mL, Sigma). Only
samples with purity ≥90% and death ≤15% were used. The
number of PMN and MN cells was determined also by flow
cytometry and the concentration adjusted, in donor’s plasma, to
1.0× 106 cells/mL.
Co-incubation of Bacteria with Whole
Human Blood and Its Circulating Immune
Factors
In 2 mL tubes, 100 µL of a suspension of 1 × 109 total BRC/mL
were mixed with 900 µL of whole human blood, PMN, or MN
at 1.0 × 106 cells/mL, plasma or TSB (containing the same
concentration of heparin as blood and its components) and
incubated at 80 rpm (in a 10mm orbit incubator), for 2 h at 37◦C.
After the co-incubation period, samples were sonicated for 5 s at
33% amplitude (Cole-Parmer) in order to lyse, and thus, decrease
eukaryotic cells contamination. Finally, bacteria were harvested
by 5 min centrifugation at 16,000 g at 4◦C and immediately
suspended in 1 mL of RNA protectTM bacteria reagent (QIAGEN,
Hilden, Germany), which was diluted 2:1 in nuclease-free water
(Gibco, MD, USA). BRC before the co-incubation assays (T0h)
were also collected. This assay was performed four independent
times using blood of four different donors (both female and
male).
RNA Isolation and Libraries Construction
for RNA Sequencing Analysis
Total RNA was isolated using RNeasy mini kit (QIAGEN).
Bacterial cell lysis was achieved by mechanical (3.0 mm
zirconium beads, Sigma) and chemical lysis (phenol, Fisher
Scientific, MA, USA) as optimized before (França et al.,
2012). RNA quality was assessed using an ExperionTM
automated electrophoresis system (Bio-Rad, CA, USA).
RNA quality indicators were above 9 for all samples.
Total RNA purified from each of the four independent co-
incubation assays performed were pooled together to decrease
donor-associated variability. Subsequently, pooled RNA was
treated with TURBO DNase (Ambion, NY, USA) and acid-
phenol:chloroform:isoamyl alcohol (125:24:1) (Ambion, MA,
USA) to degrade and isolate, respectively, contaminating
genomic DNA. Potential contaminating eukaryotic RNA was
removed using MICROBEnrichTM kit (Ambion). Prokaryotic
messenger RNA was then enriched by depleting ribosomal
RNA using Ribo-ZeroTM rRNA removal kit for Gram-positive
bacteria (Illumina, CA, USA) and transcriptomic libraries were
constructed using ScriptSeqTM RNA-seq library preparation
kit (Illumina). The quality of the libraries constructed for each
condition under study was assessed by quantitative PCR and
Hi-Sensitivity D1K TapeStation (Agilent 2200 TapeStation).
Finally, all libraries were multiplexed and sequencing data was
generated in a MiSeq R© sequencer (Illumina) from paired-end
reads (2× 150 bp).
The results obtained were validated by quantitative (q)
PCR, as described earlier (Sousa et al., 2014). Total RNA
samples utilized for RNAseq analysis were used as template.
The sequences of the primers used are shown in Supplementary
Table 1. Fold-change values were determined applying the Pfaffl
method (Pfaffl, 2004) using T0h as control.
Trimming and Data Analysis
After sequencing, adapters were trimmed by MiSeq R© internal
software during the base calling. CLC Genomics Workbench
version 5.1 (QIAGEN) was then used for quality, ambiguity,
and length trimming, alignment with S. epidermidis RP62A
(GenBank accession number: CP000029.1), normalization of
the reads per kilobase per million mapped reads (Mortazavi
et al., 2008), and for the analysis of differential gene expression.
Quality, ambiguity, and length trimming were performed
using the CLC genomics workbench default settings. The
transcriptomic alterations induced on BRC incubated with
human blood or its circulating immune cells and soluble factors
was determined using as control BRC transcriptomic profile
before co-incubation assays. Kal’s statistical test (Kal et al.,
1999), with false discovery rate (FDR) (Pawitan et al., 2005),
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was applied to identify statistically significant alterations in
gene transcription. Alterations with fold changes below 3 and
P values above 0.05 were discarded. Taking into consideration
that bacteria may change their transcriptome, in a nonspecific
manner, after being transferred in to a new environment,
we had also compared the transcriptomic alterations observed
in BRC incubated with whole blood or its cellular and
soluble components with those observed in the presence of
TSB, a standard laboratorial medium. Hence, in order to
only consider alterations induced by biological factors, genes
whose transcription was found in both groups were discarded.
Nevertheless, genes with opposite regulation in both groups
were maintained. KEGG analysis was performed using STRING
(Franceschini et al., 2013) and only gene-sets passing significance
thresholds (P < 0.05, Hypergeometric test with FDR) are
depicted. The heat map was created using CIMminer utilizing
Euclidean distance method and average linkage clustering.
DATA DEPOSITION
The transcriptomic profile of S. epidermidis BRC under the
conditions described in this study was deposited in Gene
Expression Omnibus (GEO) database, at NCBI, under the
accession number GSE79948. Raw and trimmed/filtered datasets
are available and can be downloaded as fastq and text files,
respectively.
INTERPRETATION OF DATA SETS
Bacteremia is one of the major clinical complications associated
with the release of cells from S. epidermidis biofilms formed
on intravascular catheters. These infections are associated with
increased hospitalization periods, healthcare costs and patient
morbidity, or even mortality (Kleinschmidt et al., 2015). Our
goal was thus to gather the first insights into the interaction
FIGURE 1 | Overview of the significant alterations in the gene transcription profile of BRC incubated with human blood or its cellular and soluble
components. (A) Number of genes with increased and decreased transcription; (B) Venn diagram showing the number of genes uniquely (disjointed) and commonly
expressed (overlapping) among the conditions tested; (C) Heat map showing the expression pattern as well as hierarchical clustering of all samples. The white bands
represent genes whose expression was not significantly altered (P > 0.05 and fold change <3). PMN: polymorphonuclear leukocytes, MN: mononuclear leukocytes.
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between S. epidermidis BRC and human blood, in order to better
understand the role of these cells in the pathogenesis of S.
epidermidis biofilm-related infections. To this end, we analyzed
the transcriptome of BRC upon interaction with human blood
or its cellular and soluble components, using an ex vivo model
previously used for other microorganisms (Fradin et al., 2003;
Mereghetti et al., 2008; Malachowa et al., 2011; França et al.,
2014).
The transcriptome of S. epidermidis BRC changed significantly
after incubation with whole human blood or its cellular or soluble
components. Nevertheless, before analyzing the alterations
observed, RNAseq results were confirmed using qPCR. As
can be seen in Supplementary Figure 1, a strong correlation
between both methods was observed. Thereafter, we compared
the transcriptome of BRC incubated with human blood, PMNs,
MNs, or plasma with the one of BRC incubated with TSB, a
rich medium frequently used in in vitro assays. This comparison
allowed the identification the genes whose transcription was
affected only by the presence of biological factors. Within the
genes found differentially transcribed (fold change >3 and P <
0.05, Kal’s test with FDR) only 21–25% of the genes were found
in BRC incubated with whole human blood or its cellular and
soluble components and these were the genes considered for
further analysis (Figure 1).
KEGG pathways analysis showed that the major alterations
occurring in the presence of human blood circulating factors
were associated with basic pathways involved in the biosynthesis
or metabolism of amino acids and in the import or export
of substances (Figure 2). In addition, KEGG pathways such
as biosynthesis of secondary metabolites and phenylalanine,
FIGURE 2 | KEGG pathways enriched after incubation with whole human blood or its cellular or soluble components. KEEG pathways are organized, for
each condition, from lower (top) to higher (bottom) significance. PMN, polymorphonuclear leukocytes; MN, mononuclear leukocytes.
Frontiers in Microbiology | www.frontiersin.org 4 July 2016 | Volume 7 | Article 1143
França et al. Biofilm-Released Cells Transcriptome in Blood
tyrosine, tryptophan, and folate biosynthesis were also found
significantly enriched (P < 0.05, Hypergeometric test with FDR)
but only in BRC incubated with both PMN and MN leukocytes
(Figure 2).
As it would be expected in a low free iron environment
such as human blood/plasma, iron transferrin receptors,
iron ABC transporter permeases, and iron ABC transporter
ATP binding proteins were found significantly enriched.
Interestingly, biotin metabolism was also found significantly
enriched (P < 0.05, Hypergeometric test with FDR) in all
the conditions tested. In fact, the complete biotin operon,
which is composed by the genes bioA, bioD, bioF, and bioW,
was found highly transcribed, with fold change values ranging
from 13 to 110. The same observation was made in S.
aureus after short-term incubation with either blood or plasma
(Malachowa et al., 2011). Biotin is an important cofactor
involved in prokaryotic central pathways being particularly
important during infection, as bacteria have a high demand
for micronutrients (Streit and Entcheva, 2003). Due to the
essential nature of biotin metabolism, the target of biotin
metabolism-associated proteins has been under special attention,
being considered a promising strategy to combat drug-
resistant pathogens including S. aureus (Soares da Costa
et al., 2012; Pendini et al., 2013; Paparella et al., 2014).
No enrichment was found among genes with decreased
transcription. Interestingly, in all the conditions tested, ∼40%
of the genes with down-regulated transcription encoded
hypothetical proteins or pseudogenes.
Analyzing the effect of each of the blood components
independently, using hierarchical cluster analysis, we found two
major clades: one that separates BRC incubated with whole
human blood from the remaining conditions and a second clade
that separates BRC incubated with plasma from those incubated
with either PMN or MN cells (Figure 2). Interestingly, this
suggested that both PMN and MN leukocytes, despite their
involvement in innate immunity and phagocytic capability, had
little influence on S. epidermidis BRC gene expression profile.
Also, these results indicated that the majority of the alterations
observed in whole human blood occurred in plasma, as recently
observed in a small panel of S. epidermidis genes (França and
Cerca, 2016). We cannot, however, discard the possibility that a
different effect on S. epidermidis gene expression profile could be
seen if these cells were circulating in human blood, as crosstalk
with and production of signaling molecules by other cells may
have an important influence in S. epidermidis gene expression.
CONCLUSIONS
Overall, this study enabled us to identify the pathways involved
in the adaptation of the bacterium to the stressful environment
encountered in human blood consequently contributing to its
survival and persistence. Hence, these results may be helpful
in the selection of potential targets for future studies aiming
to develop preventive and/or therapeutic strategies for S.
epidermidis biofilm-based infections. One interesting target may
be biotin metabolism-associated proteins, which are already
being tackled in other important human pathogens.
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